Eli Lilly and Company (LLY) fair value analysis
S&P 500 · Updated 2026-08-30
Forward Fair Value verdict
UndervaluedBased on TickrTrends' weekly Forward Fair Value model, LLY is trading at more than a 25% discount to estimated fair value.
- Last price
- $1,174.61
- Sector
- Healthcare
- 12-month range
- $735.19–$1,148.84
What our data shows for LLY
- Our model validated 16 trailing price-to-earnings windows for LLY, built from quarterly earnings records.
- Shares are trading in the upper third of their 12-month price range of $735.19–$1,148.84.
- The 14-day relative strength index sits at a neutral 43.
- 3 of the last 12 weekly snapshots showed positive price momentum.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for LLY
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
How Forward Fair Value works
TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.